STOCK TITAN

Immunocore: Point72 reports 5.2% shared stake

The reported position includes 501,604 ordinary shares represented by ADSs issuable upon conversion of convertible notes.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

For Immunocore Holdings plc (IMCR), Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen each reported shared beneficial ownership of 2,720,043 ordinary shares and shared voting and dispositive power over that amount, equal to 5.2% of the class, as of November 6, 2026.

The reported amount includes 501,604 ordinary shares represented by ADSs issuable upon conversion of convertible notes. Point72 Asset Management maintains investment and voting power over securities held by Point72 Associates, LLC, which has the right to receive or direct dividends or sale proceeds from more than 5% of the outstanding ordinary shares. The reporting persons state they directly own no ordinary shares and that the report is not an admission of beneficial ownership under the Act. Jason M. Colombo signed as an authorized person.

Beneficial ownership 2,720,043 ordinary shares Reported by each of the three reporting persons as of November 6, 2026
Percent of class 5.2% As of November 6, 2026
Shared voting power 2,720,043 ordinary shares Reported by each reporting person as of November 6, 2026
Shared dispositive power 2,720,043 ordinary shares Reported by each reporting person as of November 6, 2026
Shares issuable upon conversion 501,604 ordinary shares Represented by ADSs and included in the reported position
ADS ratio 1 ADS represents 1 ordinary share Immunocore securities
beneficially owned financial
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power financial
"Shared Voting Power 2,720,043.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 2,720,043.00"
convertible notes financial
"issuable upon conversion of convertible notes"
Convertible notes are a type of short-term loan that a company receives from investors, which can later be turned into company shares instead of being paid back in cash. They matter to investors because they offer a way to support a company early on while giving the potential to own a stake in its success if the company grows and later raises more funding.
American Depositary Shares financial
"American Depositary Shares ("ADSs")"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IMCR ordinary shares did the Point72 reporting persons report?

Each of Point72 Asset Management, Point72 Capital Advisors, and Steven A. Cohen reported shared beneficial ownership of 2,720,043 ordinary shares, equal to 5.2% of the class, as of November 6, 2026.

What does the reported IMCR share position include?

The reported position includes 501,604 ordinary shares represented by ADSs issuable upon conversion of convertible notes. Each ADS represents one ordinary share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





45258D105

(CUSIP Number)
11/06/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The Ordinary Shares (as defined in Item 2(a)) reported herein are represented by ADSs (as defined in Item 2(a)) and includes 501,604 Ordinary Shares represented by ADSs issuable upon conversion of convertible notes.


SCHEDULE 13G




Comment for Type of Reporting Person: The Ordinary Shares reported herein are represented by ADSs and includes 501,604 Ordinary Shares represented by ADSs issuable upon conversion of convertible notes.


SCHEDULE 13G




Comment for Type of Reporting Person: The Ordinary Shares reported herein are represented by ADSs and includes 501,604 Ordinary Shares represented by ADSs issuable upon conversion of convertible notes.


SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:11/09/2026
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:11/09/2026
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:11/09/2026
Exhibit Information

Exhibit 99.1: Joint Filing Agreement

Keep reading